Arcus Biosciences Inc share price logo

Arcus Biosciences Inc Share Price

NYSE: RCUS

Small Cap

$12.03

+0.28

(+2.38%)

as on

Arcus Biosciences Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $11.68
    $12.41
    downward going graph

    2.91%

    Downside

    3.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.5
    $18.98
    downward going graph

    45.97%

    Downside

    57.77%

    Upside

    downward going graph

Arcus Biosciences Inc share price movements today

Previous Close
$11.75
Open
$11.69
Volume
651.6K
Day's Low - High
$11.68 - $12.41
52 Week Low - High
$6.5 - $18.98

Arcus Biosciences Inc Historical Returns

1 Month Return
+ 12.23 %
3 Month Return
+ 38.07 %
1 Year Return
-28.74 %
3 Year Return
-54.67 %
5 Year Return
-46.44 %

Arcus Biosciences Inc Stock Fundamentals & Key Indicators

Check Arcus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-3.708

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.36

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

0

EBITDA

-328.0M

Revenue (TTM)

262.0M

Profit Margin

-113.74%

Return On Equity TTM

3403900.00%

Arcus Biosciences Inc Stock Valuation

Track how Arcus Biosciences Inc P/E has moved over time to understand its valuation trends.

Arcus Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (28.75x)

September 30, 2022

Today (-6.36x)

September 18, 2025

Industry (-3.94x)

September 18, 2025

Highest (90.21x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -6.36x

Arcus Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.3B-46.44%-6.36-113.74%
BUY$60.5B248.74%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Arcus Biosciences Inc Stock including INR - Dollar returns

The Arcus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arcus Biosciences Inc investment value today

Current value as on today

₹77,552

Returns

₹22,448

(-22.45%)

Returns from Arcus Biosciences Inc Stock

₹27,047 (-27.05%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Arcus Biosciences Inc Stock

Based on 18 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Arcus Biosciences Inc. Average target price of $28.36

Arcus Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Arcus Biosciences Inc.

What analysts predicted

57.58%UPSIDE

Target Price

$28.36

Current Price

$12.03

Analyzed by

18 Analysts

Target

$28.36

Arcus Biosciences Inc target price $28.36, a slight upside of 57.58% compared to current price of $12.03. According to 18 analysts rating.

Arcus Biosciences Inc Stock's Interest Amongst Investors

Search interest for Arcus Biosciences Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Arcus Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
25
29
32
31
145
39
48
26
28
160
Gross Profit
25
29
32
31
145
39
48
26
28
160
Operating Income
-86
-83
-80
-91
-16
-106
-105
-103
-122
-8
EBITDA
-75
-72
-67
-77
20
-91
-89
-89
-108
4
Interest Expense
1
-
1
2
1
-
1
2
1
2
Depreciation
2
2
1
3
3
2
2
3
3
2
Income Before Tax
-78
-74
-69
-80
-4
-93
-92
-94
-112
-8
Income Tax Expense
2
1
2
1
1
-
-
1
-
-
Net Income
-80
-75
-71
-81
-4
-93
-92
-94
-112
-8
Net Profit Margin
-320.00%
-258.62%
-221.88%
-261.29%
-2.76%
-238.46%
-191.67%
-361.54%
-400.00%
-5.00%

Arcus Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
1
8
15
78
383
112
117
258
Gross Profit
-1
1
8
15
78
383
112
117
258
Operating Income
-18
-53
-54
-88
-124
54
-280
-340
-330
EBITDA
-16
-50
-51
-85
-120
59
-258
-291
-269
Interest Expense
-
-
4
-
-
0
2
2
4
Depreciation
-
2
3
3
4
3
6
8
10
Income Before Tax
-17
-53
-49
-84
-123
55
-266
-301
-283
Income Tax Expense
-
-
5
-8
-6
2
1
6
1
Net Income
-17
-53
-49
-75
-123
53
-267
-307
-283
Net Profit Margin
0.00%
-3756.69%
-593.73%
-506.21%
-157.69%
13.84%
-238.39%
-262.39%
-109.69%

Arcus Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-75
-71
-81
-4
-93
-92
-94
-112
-
Operating Cash Flow
-57
-63
-88
-2
-94
26
-100
-132
-133
Investing Cash Flow
26
11
28
-169
63
-29
51
32
137
Financing Cash Flow
23
6
3
229
2
48
-2
142
52
Change in Cash
-8
-46
-57
58
-29
45
-51
42
56

Arcus Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-53
-49
-84
-122
52
-267
-307
-283
Operating Cash Flow
-25
-42
-73
111
-256
438
-306
-170
Investing Cash Flow
-49
-113
59
-434
-3
-413
194
-84
Financing Cash Flow
107
129
1
438
237
33
33
277
Change in Cash
33
-27
-13
115
-22
58
-79
23

Global Institutional Holdings in Arcus Biosciences Inc

Funds
Holdings
BlackRock Inc
10.21%
Vanguard Group Inc
6.29%
Woodline Partners LP
4.82%
FMR Inc
4.19%
State Street Corp
3.47%

Insights on Arcus Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 26.0M → 160.0M (in $), with an average increase of 44.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RCUS stock has moved up by 4.6%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -112.0M → -8.0M (in $), with an average increase of 1300.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 165.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 95.4%

About Arcus Biosciences Inc

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world’s largest biotechnology research hub. unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. for this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive. arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. these new drugs will then be
OrganisationArcus Biosciences Inc
Headquarters3928 Point Eden Way, Hayward, CA, United States, 94545
IndustryHealth Technology
CEODr. Terry J. Rosen Ph.D.
E-voting on sharesClick here to vote

Key Management of Arcus Biosciences Inc

Name

Title

Ms. Jennifer A. Jarrett M.B.A.

Chief Operating Officer

Dr. K. Christopher Garcia Ph.D.

Co-Founder & Member of Scientific Advisory Board

Dr. Jonathan Yingling Ph.D.

Chief Scientific Officer

Pia Eaves

Vice President of Investor Relations & Strategy

Ms. Carolyn C. Tang J.D.

General Counsel & Corporate Secretary

Dr. Juan Carlos Jaen Ph.D.

Co- Founder & President

Mr. Robert C. Goeltz II

Principal Financial Officer & CFO

Holli Kolkey

Vice President of Corporate Communications

Dr. Terry J. Rosen Ph.D.

Co-Founder, Chairman & CEO

Mr. Alexander Azoy CPA

VP of Finance & Principal Accounting Officer

FAQs

What is Arcus Biosciences Inc share price today?

Arcus Biosciences Inc share price today is $12.03 as on at the close of the market. Arcus Biosciences Inc share today touched a day high of $12.41 and a low of $11.68.

What is the 52 week high and 52 week low for Arcus Biosciences Inc share?

Arcus Biosciences Inc share touched a 52 week high of $18.98 on and a 52 week low of $6.5 on . Arcus Biosciences Inc stock price today i.e. is closed at $12.03,which is 36.62% down from its 52 week high and 85.08% up from its 52 week low.

What is Arcus Biosciences Inc's market capitalisation today?

Arcus Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Arcus Biosciences Inc Stock (RCUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcus Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcus Biosciences Inc Shares that will get you 0.1247 shares as per Arcus Biosciences Inc share price of $12.03 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Arcus Biosciences Inc Stock (RCUS) from India?

Indian investors can start investing in Arcus Biosciences Inc (RCUS) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Arcus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcus Biosciences Inc share’s latest price of $12.03 as on September 18, 2025 at 1:29 am IST, you will get 0.8313 shares of Arcus Biosciences Inc. Learn more about fractional shares .

What are the returns that Arcus Biosciences Inc has given to Indian investors in the last 5 years?

Arcus Biosciences Inc stock has given -46.44% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?